HK Stock MarketDetailed Quotes

00390 CHINA RAILWAY

Watchlist
  • 3.830
  • +0.150+4.08%
Market Closed Sep 27 16:08 CST
94.79BMarket Cap2.75P/E (TTM)

CHINA RAILWAY Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Turnover
-7.83%544.52B
-2.56%265.01B
9.45%1.26T
4.09%882.92B
5.38%590.77B
2.04%271.97B
7.55%1.15T
10.45%848.18B
12.52%560.59B
12.82%266.54B
Special items of operating revenue
----
-2.56%634.19M
----
-14.16%1.6B
----
16.13%650.83M
----
-18.54%1.87B
----
-29.92%560.44M
Operating income
-7.83%544.52B
-2.56%265.65B
9.45%1.26T
4.05%884.52B
5.38%590.77B
2.07%272.62B
7.55%1.15T
10.37%850.05B
12.52%560.59B
12.68%267.1B
Cost of sales
7.80%-497.77B
----
-9.11%-1.14T
----
-5.02%-539.86B
----
-7.79%-1.05T
----
-12.61%-514.04B
----
Operating expenses
7.80%-497.77B
2.21%-242.26B
-9.11%-1.14T
-3.81%-802.67B
-5.02%-539.86B
-2.15%-247.74B
-7.79%-1.05T
-10.82%-773.19B
-12.61%-514.04B
-13.39%-242.52B
Gross profit
-8.15%46.76B
-6.02%23.38B
12.67%122.69B
6.48%81.85B
9.36%50.91B
1.23%24.88B
5.32%108.89B
5.98%76.86B
11.45%46.55B
6.13%24.58B
Selling expenses
5.15%-2.91B
10.82%-1.35B
-8.25%-6.85B
-6.27%-4.42B
-13.30%-3.07B
-12.83%-1.51B
-6.39%-6.33B
-8.09%-4.16B
-14.13%-2.71B
-14.86%-1.34B
Administrative expenses
1.72%-12.9B
-4.18%-6.71B
-9.64%-28.96B
-4.90%-18.86B
-7.39%-13.13B
-4.38%-6.44B
-3.84%-26.41B
-4.54%-17.98B
2.32%-12.23B
-1.76%-6.17B
Research and development expenses
10.36%-9.23B
9.64%-3.47B
-8.14%-30B
-12.50%-17.81B
-14.60%-10.29B
14.27%-3.84B
-12.06%-27.74B
-15.84%-15.83B
---8.98B
-16.39%-4.48B
Profit from asset sales
----
-40.01%149.42M
----
1,357.38%232.19M
----
883.22%249.08M
----
-107.23%-18.47M
----
-65.72%25.33M
Revaluation surplus
----
-83.41%-84.69M
----
-3.69%-331.53M
----
60.29%-46.18M
----
-49.59%-319.74M
----
-89.29%-116.28M
-Changes in the fair value of other assets
----
-83.41%-84.69M
----
-3.69%-331.53M
----
60.29%-46.18M
----
-49.59%-319.74M
----
-89.29%-116.28M
Impairment and provision
5.34%-1.76B
39.87%-665.18M
-113.79%-7.15B
37.04%-2.34B
-31.28%-1.86B
-30.50%-1.11B
38.97%-3.34B
12.68%-3.71B
-2.24%-1.41B
0.46%-847.62M
-Other impairment is provision
5.34%-1.76B
39.87%-665.18M
-113.79%-7.15B
37.04%-2.34B
-31.28%-1.86B
-30.50%-1.11B
38.97%-3.34B
12.68%-3.71B
-2.24%-1.41B
0.46%-847.62M
Operating interest expense
----
-29.89%-181.29M
----
-66.02%-299.83M
----
-774.96%-139.57M
----
68.01%-180.6M
----
90.07%-15.95M
Special items of operating profit
-718.68%-563M
-25.65%844.91M
-101.42%-2.56B
-35.60%1.37B
-74.00%91M
24.46%1.14B
67.60%-1.27B
59.90%2.13B
104.80%350M
56.46%913M
Operating profit
-14.36%19.4B
-8.82%10.83B
7.71%47.17B
8.16%35.26B
5.01%22.66B
6.30%11.88B
15.72%43.79B
6.50%32.6B
18.51%21.58B
7.39%11.18B
Financing income
3.35%4.45B
----
21.34%8.71B
----
45.57%4.3B
----
17.61%7.18B
----
32.20%2.96B
----
Financing cost
-3.65%-5.74B
9.44%-1.02B
-24.17%-11.89B
-56.34%-3.27B
-34.31%-5.54B
-16.04%-1.13B
-25.76%-9.58B
33.69%-2.09B
-37.92%-4.12B
38.40%-972.23M
Share of profits of associates
-23.96%1.66B
----
-1.44%4.67B
----
6.63%2.19B
----
24.28%4.73B
----
74.55%2.05B
----
Share of profit from joint venture company
66.46%-214M
----
25.19%-1.08B
----
-13.12%-638M
----
-183.43%-1.44B
----
-161.11%-564M
----
Special items of earning before tax
----
128.49%51.13M
----
-76.88%17.22M
----
-85.94%22.38M
----
123.33%74.49M
----
275.23%159.14M
Earning before tax
-14.85%19.56B
-8.47%9.86B
6.46%47.58B
4.66%32.01B
4.91%22.97B
3.97%10.77B
12.76%44.69B
12.69%30.59B
18.93%21.9B
18.59%10.36B
Tax
17.35%-3.89B
3.81%-1.83B
-2.25%-9.94B
-2.55%-5.69B
7.49%-4.71B
7.23%-1.91B
-6.10%-9.73B
-14.17%-5.55B
-25.28%-5.09B
-19.76%-2.06B
After-tax profit from continuing operations
-14.21%15.67B
-9.47%8.03B
7.64%37.64B
5.13%26.32B
8.66%18.26B
6.74%8.87B
14.76%34.97B
12.36%25.04B
17.13%16.81B
18.31%8.31B
After-tax profit from non-continuing business
----
----
----
--0
----
----
----
--0
----
--0
Earning after tax
-14.21%15.67B
-9.47%8.03B
7.64%37.64B
5.13%26.32B
8.66%18.26B
6.74%8.87B
14.76%34.97B
12.36%25.04B
17.13%16.81B
18.31%8.31B
Minority profit
-31.36%1.39B
-44.75%545.85M
12.45%4.15B
13.69%2.31B
19.61%2.03B
37.32%987.93M
29.52%3.69B
24.21%2.03B
34.90%1.69B
34.28%719.41M
Adjustment items of profit attributable to shareholders
----
----
----
--2K
----
--2K
----
----
----
----
Profit attributable to shareholders
-12.07%14.28B
-5.04%7.48B
7.07%33.48B
4.37%24.01B
7.44%16.24B
3.84%7.88B
13.23%31.27B
11.43%23.01B
15.43%15.12B
16.99%7.59B
Basic earnings per share
-12.07%0.532
-5.25%0.289
8.01%1.294
4.82%0.913
9.80%0.605
3.74%0.305
15.53%1.198
19.15%0.871
21.37%0.551
23.53%0.294
Diluted earnings per share
-12.07%0.532
-5.25%0.289
7.85%1.292
4.82%0.913
9.80%0.605
3.74%0.305
15.53%1.198
19.15%0.871
21.37%0.551
23.53%0.294
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Auditor
--
--
PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership)
--
--
--
PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Turnover -7.83%544.52B-2.56%265.01B9.45%1.26T4.09%882.92B5.38%590.77B2.04%271.97B7.55%1.15T10.45%848.18B12.52%560.59B12.82%266.54B
Special items of operating revenue -----2.56%634.19M-----14.16%1.6B----16.13%650.83M-----18.54%1.87B-----29.92%560.44M
Operating income -7.83%544.52B-2.56%265.65B9.45%1.26T4.05%884.52B5.38%590.77B2.07%272.62B7.55%1.15T10.37%850.05B12.52%560.59B12.68%267.1B
Cost of sales 7.80%-497.77B-----9.11%-1.14T-----5.02%-539.86B-----7.79%-1.05T-----12.61%-514.04B----
Operating expenses 7.80%-497.77B2.21%-242.26B-9.11%-1.14T-3.81%-802.67B-5.02%-539.86B-2.15%-247.74B-7.79%-1.05T-10.82%-773.19B-12.61%-514.04B-13.39%-242.52B
Gross profit -8.15%46.76B-6.02%23.38B12.67%122.69B6.48%81.85B9.36%50.91B1.23%24.88B5.32%108.89B5.98%76.86B11.45%46.55B6.13%24.58B
Selling expenses 5.15%-2.91B10.82%-1.35B-8.25%-6.85B-6.27%-4.42B-13.30%-3.07B-12.83%-1.51B-6.39%-6.33B-8.09%-4.16B-14.13%-2.71B-14.86%-1.34B
Administrative expenses 1.72%-12.9B-4.18%-6.71B-9.64%-28.96B-4.90%-18.86B-7.39%-13.13B-4.38%-6.44B-3.84%-26.41B-4.54%-17.98B2.32%-12.23B-1.76%-6.17B
Research and development expenses 10.36%-9.23B9.64%-3.47B-8.14%-30B-12.50%-17.81B-14.60%-10.29B14.27%-3.84B-12.06%-27.74B-15.84%-15.83B---8.98B-16.39%-4.48B
Profit from asset sales -----40.01%149.42M----1,357.38%232.19M----883.22%249.08M-----107.23%-18.47M-----65.72%25.33M
Revaluation surplus -----83.41%-84.69M-----3.69%-331.53M----60.29%-46.18M-----49.59%-319.74M-----89.29%-116.28M
-Changes in the fair value of other assets -----83.41%-84.69M-----3.69%-331.53M----60.29%-46.18M-----49.59%-319.74M-----89.29%-116.28M
Impairment and provision 5.34%-1.76B39.87%-665.18M-113.79%-7.15B37.04%-2.34B-31.28%-1.86B-30.50%-1.11B38.97%-3.34B12.68%-3.71B-2.24%-1.41B0.46%-847.62M
-Other impairment is provision 5.34%-1.76B39.87%-665.18M-113.79%-7.15B37.04%-2.34B-31.28%-1.86B-30.50%-1.11B38.97%-3.34B12.68%-3.71B-2.24%-1.41B0.46%-847.62M
Operating interest expense -----29.89%-181.29M-----66.02%-299.83M-----774.96%-139.57M----68.01%-180.6M----90.07%-15.95M
Special items of operating profit -718.68%-563M-25.65%844.91M-101.42%-2.56B-35.60%1.37B-74.00%91M24.46%1.14B67.60%-1.27B59.90%2.13B104.80%350M56.46%913M
Operating profit -14.36%19.4B-8.82%10.83B7.71%47.17B8.16%35.26B5.01%22.66B6.30%11.88B15.72%43.79B6.50%32.6B18.51%21.58B7.39%11.18B
Financing income 3.35%4.45B----21.34%8.71B----45.57%4.3B----17.61%7.18B----32.20%2.96B----
Financing cost -3.65%-5.74B9.44%-1.02B-24.17%-11.89B-56.34%-3.27B-34.31%-5.54B-16.04%-1.13B-25.76%-9.58B33.69%-2.09B-37.92%-4.12B38.40%-972.23M
Share of profits of associates -23.96%1.66B-----1.44%4.67B----6.63%2.19B----24.28%4.73B----74.55%2.05B----
Share of profit from joint venture company 66.46%-214M----25.19%-1.08B-----13.12%-638M-----183.43%-1.44B-----161.11%-564M----
Special items of earning before tax ----128.49%51.13M-----76.88%17.22M-----85.94%22.38M----123.33%74.49M----275.23%159.14M
Earning before tax -14.85%19.56B-8.47%9.86B6.46%47.58B4.66%32.01B4.91%22.97B3.97%10.77B12.76%44.69B12.69%30.59B18.93%21.9B18.59%10.36B
Tax 17.35%-3.89B3.81%-1.83B-2.25%-9.94B-2.55%-5.69B7.49%-4.71B7.23%-1.91B-6.10%-9.73B-14.17%-5.55B-25.28%-5.09B-19.76%-2.06B
After-tax profit from continuing operations -14.21%15.67B-9.47%8.03B7.64%37.64B5.13%26.32B8.66%18.26B6.74%8.87B14.76%34.97B12.36%25.04B17.13%16.81B18.31%8.31B
After-tax profit from non-continuing business --------------0--------------0------0
Earning after tax -14.21%15.67B-9.47%8.03B7.64%37.64B5.13%26.32B8.66%18.26B6.74%8.87B14.76%34.97B12.36%25.04B17.13%16.81B18.31%8.31B
Minority profit -31.36%1.39B-44.75%545.85M12.45%4.15B13.69%2.31B19.61%2.03B37.32%987.93M29.52%3.69B24.21%2.03B34.90%1.69B34.28%719.41M
Adjustment items of profit attributable to shareholders --------------2K------2K----------------
Profit attributable to shareholders -12.07%14.28B-5.04%7.48B7.07%33.48B4.37%24.01B7.44%16.24B3.84%7.88B13.23%31.27B11.43%23.01B15.43%15.12B16.99%7.59B
Basic earnings per share -12.07%0.532-5.25%0.2898.01%1.2944.82%0.9139.80%0.6053.74%0.30515.53%1.19819.15%0.87121.37%0.55123.53%0.294
Diluted earnings per share -12.07%0.532-5.25%0.2897.85%1.2924.82%0.9139.80%0.6053.74%0.30515.53%1.19819.15%0.87121.37%0.55123.53%0.294
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)
Audit Opinions ----Unqualified Opinion------Unqualified Opinion------
Auditor ----PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership)------PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data